zavondemstat   Click here for help

GtoPdb Ligand ID: 12807

Synonyms: Example 187 [WO2015200709A1]
Compound class: Synthetic organic
Comment: The INN record for zavondemstat describes it as a lysine-specific histone demethylase 4 (KDM4) inhibitor. Zavondemstat was developed for antineoplastic potential. The chemical structure provided for the INN matches example 187 in Quanticel Pharmaceuticals' patent WO2015200709A1 [1]. It was tested for inhibitory activity against KDM4C (JMJD2C) and KDM6B (JMJD3) in the analysis provided in the patent.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 74.16
Molecular weight 431.53
XLogP 3.56
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)C1=CC=C(C=C1)N(C)C2=CC=C3[C@@H](CCOC3=C2)CNC4=CN=CC=C4C(=O)O
Isomeric SMILES CN(C1=CC=C(C=C1)C(C)C)C2=CC3=C([C@@H](CCO3)CNC=4C=NC=CC4C(=O)O)C=C2
InChI InChI=1S/C26H29N3O3/c1-17(2)18-4-6-20(7-5-18)29(3)21-8-9-22-19(11-13-32-25(22)14-21)15-28-24-16-27-12-10-23(24)26(30)31/h4-10,12,14,16-17,19,28H,11,13,15H2,1-3H3,(H,30,31)/t19-/m0/s1
InChI Key NDVITLLKZQXKGU-IBGZPJMESA-N
References
1. Boloor A, Chen YK, Wallace MB. (2015)
Histone demethylase inhibitors.
Patent number: WO2015200709A1. Assignee: Quanticel Pharmaceuticals, Inc.. Priority date: 25/06/2015. Publication date: 30/12/2015.